The largest drug
discovery company
in the CEE region

More

Your integrated drug
discovery partner of choice

More

Developing breakthrough
therapies in oncology

More

Delivering comprehensive
research solutions to biotech
and pharma

More

News See all

Selvita Announces Presentations on CDK8 Inhibitor SEL120 at the…

Krakow, Poland – 21 November 2018 – Selvita (WSE:SLV), a clinical stage drug discovery and development company engaged in the...
More

Selvita demonstrates dynamic business growth in Q3 2018

Krakow, Poland – 20 November 2018 – Selvita (WSE: SLV), a clinical stage drug discovery and development company engaged in...
More

Selvita to Present New Data from SEL120 Program at…

Krakow, Poland - 8 November 2018 – Selvita (WSE:SLV), a clinical stage drug discovery and development company engaged in the...
More

Selvita presents at BIO-Europe 2018

Kraków, Poland – 2 November 2018 – Selvita (WSE: SLV), a clinical stage drug discovery and development company focused on...
More

Selvita to present new data from its oncology programs…

Krakow, Poland - 31 October 2018 – Selvita (WSE: SLV), a clinical stage drug discovery and development company focused on...
More

About Selvita

Selvita has two primary focus areas:

– to serve the drug discovery market as a customer centric provider of high quality, integrated drug discovery services and

– as a drug discovery company engaged in the research and development of breakthrough therapies in oncology.

More

Drug Discovery Services

Selvita is a global integrated drug discovery partner for the pharmaceutical and biotechnology industries.

We offer drug discovery support at every stage of the early discovery phase up to the preclinical research phase.

More

Research and Development

In its internal research and development efforts, Selvita focuses on different dimensions of oncology.


The company’s most advanced R&D program is SEL24, a dual PIM/FLT3 kinase inhibitor currently in Phase I/II clinical study, in acute myeloid leukemia.

More

Investor Relations SLV 0,00 PLN ( 0,00% )

Share price 2018-12-11 09:00:00

49,00 PLN More

Careers

We are a multicultural and a multinational company employing professionals from all over the world.

Find out who we’re courrently looking for and what we can offer our employees.

More